SOM 1.25% 39.5¢ somnomed limited

biomaterial prospects

  1. 87 Posts.
    Malmanu
    you are a powerhouse of information on the shareholders, very useful to know who is pulling the strings so to speak...


    By the way back at the beginning of the year in the media release they were very positive for future uses of the biomaterial...

    “This is a milestone development for SomnoMed” said Ralf Barschow, chief executive of SomnoMed Limited. “We are currently assessing various marketing and distribution options to introduce this novel material to the markets around the world. We have already been approached
    by large, reputable companies seeking a license, private label agreements or simply supply.”

    SomnoMed is assessing the global application and potential for SMH BFlex, especially outside the dental industry. “The global applications for SMH BFlex could be substantial and we will only make final decisions on how to distribute the material once thorough investigations are completed,” said
    Barschow.

    It must be due time to hear about any progress on this promising front.
 
watchlist Created with Sketch. Add SOM (ASX) to my watchlist
(20min delay)
Last
39.5¢
Change
-0.005(1.25%)
Mkt cap ! $85.36M
Open High Low Value Volume
40.0¢ 40.0¢ 37.0¢ $20.82K 54.33K

Buyers (Bids)

No. Vol. Price($)
2 29105 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 6350 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
SOM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.